Nano-X Imaging Ltd. (NASDAQ:NNOX – Get Free Report) CEO Erez Meltzer bought 36,000 shares of the company’s stock in a transaction that occurred on Monday, July 27th. The shares were purchased at an average price of $0.93 per share, with a total value of $33,480.00. Following the transaction, the chief executive officer directly owned 36,000 shares in the company, valued at $33,480. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Nano-X Imaging Stock Down 0.9%
Shares of NNOX stock opened at $0.88 on Wednesday. Nano-X Imaging Ltd. has a 12-month low of $0.73 and a 12-month high of $5.15. The company has a market capitalization of $61.08 million, a P/E ratio of -0.56 and a beta of 1.24. The firm has a 50-day moving average price of $1.47 and a 200 day moving average price of $2.08.
Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last released its quarterly earnings results on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. The firm had revenue of $4.31 million during the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. As a group, research analysts expect that Nano-X Imaging Ltd. will post -0.6 earnings per share for the current year.
Nano-X Imaging News Summary
- Positive Sentiment: CEO Erez Meltzer purchased 36,000 NNOX shares at an average price of $0.93, investing approximately $33,480. The insider purchase may signal management confidence, although the relatively small transaction is unlikely to offset broader concerns. SEC insider ownership filing
- Neutral Sentiment: Rosen Law Firm, Portnoy Law, Robbins LLP, Pomerantz LLP, Gross Law Firm and other firms reminded investors of the pending litigation and lead-plaintiff deadline. Most of these announcements are investor solicitations rather than new operating updates, but their volume increases the visibility of the dispute. Rosen Law Firm deadline notice Pomerantz class action announcement
- Negative Sentiment: The class action alleges that Nano-X and certain officers made materially misleading statements or failed to disclose rising cash burn and operating expenses before the company recorded a $17.5 million impairment. The allegations concern securities purchased between March 31, 2025 and April 17, 2026 and have not been proven in court. SueWallSt class action notice
Hedge Funds Weigh In On Nano-X Imaging
Institutional investors have recently modified their holdings of the stock. AQR Capital Management LLC acquired a new position in shares of Nano-X Imaging during the first quarter worth approximately $178,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Nano-X Imaging by 232.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company’s stock valued at $10,793,000 after purchasing an additional 1,510,806 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Nano-X Imaging by 17.5% in the second quarter. Geode Capital Management LLC now owns 810,322 shares of the company’s stock valued at $4,189,000 after purchasing an additional 120,460 shares in the last quarter. Cetera Investment Advisers raised its position in Nano-X Imaging by 82.0% in the 2nd quarter. Cetera Investment Advisers now owns 48,056 shares of the company’s stock worth $248,000 after purchasing an additional 21,657 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its position in Nano-X Imaging by 61.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 65,783 shares of the company’s stock worth $340,000 after purchasing an additional 25,048 shares during the last quarter. 21.49% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Wednesday, July 8th. Zacks Research upgraded Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. Alliance Global Partners lowered Nano-X Imaging from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $5.00 to $3.00 in a research note on Tuesday, July 7th. Finally, D. Boral Capital restated a “buy” rating and set a $5.00 target price on shares of Nano-X Imaging in a report on Monday, April 20th. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Nano-X Imaging presently has a consensus rating of “Moderate Buy” and an average price target of $4.00.
Check Out Our Latest Stock Report on NNOX
About Nano-X Imaging
Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.
The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.
Featured Stories
- Five stocks we like better than Nano-X Imaging
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
